There is increasing evidence that local thyroid hormone (TH) availability changes profoundly in 2 inflammatory conditions due to altered expression of deiodinases that metabolize TH. It is largely 3 unknown, however, how inflammation affects TH availability via the expression of TH transporters. In 4 this study we examined the effect of bacterial lipopolysaccharide (LPS) administration on two TH 5 transporters that are critically important for brain TH homeostasis, organic anion-transporting polypeptide 6 1c1 (OATP1c1) and monocarboxylate transporter 8 (MCT8). Messenger RNA levels were studied by in 7 situ hybridization and quantitative PCR, and protein levels by immunofluorescence in both the rat and 8 mouse forebrain. The mRNA of both transporters decreased robustly in the first 9h after LPS injection, 9 selectively in brain blood vessels; OATP1c1 mRNA in astrocytes and MCT8 mRNA in neurons remained 10 unchanged. At 24 and/or 48h after LPS administration, OATP1c1 and MCT8 mRNAs increased 11 markedly above control levels in brain vessels. OATP1c1 protein decreased markedly in vessels by 24h, 12 whereas MCT8 protein levels did not decrease significantly. These changes were highly similar in mice 13 and rats. The data demonstrate that OATP1c1 and MCT8 expression are regulated in a parallel manner 14 during inflammation at the blood-brain barrier of rodents. Given the indispensable role of both 15 transporters in allowing TH access to the brain, the results suggest reduced brain TH uptake during 16 systemic inflammation. 
Introduction 1
It is well known that thyroid hormone (TH) homeostasis is altered in association with acute and chronic 2 illnesses, a disorder commonly referred to as the nonthyroidal illness syndrome and manifested by 3 reduced serum TH levels and an inappropriately low TSH (1-3). However, there is limited understanding 4 about how TH availability changes at the level of specific target cells and tissues under these conditions. 5
Local TH availability is largely determined by the presence of TH transporters that enable the passage of 6 TH across cellular membranes, and deiodinases that metabolize TH (4, 5). Deiodinases have been studied 7 extensively in animal models of inflammatory conditions (1), particularly type 2 deiodinase (D2) that 8 activates T4 to the biologically more potent T3 (4). In these models, D2 expression increases in several 9 organs (6-15), including novel expression in cells and tissues where it is not normally present (6, 8, 15) , 10 suggesting a local anti-inflammatory role for TH (6, 8, (16) (17) (18) . In contrast, it is largely unknown how 11 inflammation affects TH availability via TH transporters. Quantitative PCR studies reported decreased 12 monocarboxylate transporter 8 (MCT8, coded by Slc16a2) expression in several organs of septic pigs (19) 13 and in the subcutaneous fat of septic patients (20), while organic anion-transporting polypeptide 1c1 14 (OATP1c1, coded by Slco1c1) and monocarboxylate transporter 10 (MCT10) mRNAs increased in the 15 hypothalamus of rabbits in prolonged critical illness (21) . Details of these responses, such as cell-type 16 specificity, temporal characteristics, and whether mRNA changes translate into protein levels, have not 17 yet been studied. Shedding light on these aspects of TH handling would be important to better understand 18 TH availability during disease at the cellular level. 19
Previously, we described how inflammation affects D2 expression in the brain of different rodent species, 20 and demonstrated inflammation-induced D2 expression in the leptomeninges, choroid plexus and a subset 21 of brain blood vessels (15). The present study was conducted to obtain a detailed, cell-type-specific 22 insight into the inflammatory regulation of TH transporters. Of the several proteins capable of TH 23 transport and present in the rodent brain (22, 23), we focused on OATP1c1 and MCT8 because they are 24 critically important for brain TH homeostasis (24). Both transporters facilitate TH traffic in multiple cell 25 OATP1c1; 24 days for mouse MCT8; two exposure times, 5 days and 9 days, were used for two different 1 hybridizations for rat OATP1c1; 35 days for rat MCT8; and 14 days for rat D2. Autoradiograms were 2 developed with Kodak D19 developer (Eastman Kodak Co). Sections were immersed in 0.0005% cresyl 3 violet acetate (Sigma-Aldrich) for 2 min to obtain fluorescent labeling of cell nuclei, dehydrated in 4 ascending ethanol series and xylenes, and coverslipped with DPX (Sigma-Aldrich). Darkfield images of 5 the emulsion autoradiographs and fluorescent images of the cresyl violet signal were captured using a 6
Zeiss Axioplan 2 microscope equipped with a SPOT Slider digital camera (Diagnostic Instruments). 7 8
Isotopic OATP1c1 in situ hybridization combined with GFAP immunofluorescence 9
Sections from the control and 9h LPS groups from both species were hybridized for OATP1c1 as above, 10 then processed further for immunofluorescence. The sections were treated with the mixture of 0.5% 11 Triton X-100 and 0.5% H2O2 for 15 min, rinsed in PBS (3×10 min), immersed in maleate buffer (pH 7.5) 12 for 10 min, and then in 1% blocking reagent for nucleic acid hybridization (Roche). The sections were 13 incubated overnight in a mouse monoclonal antibody against the astrocyte marker, glial fibrillary acidic 14 protein (GFAP) (Cat# MAB360, Millipore, diluted 1:1,000), and subsequently in Alexa Fluor 488-15 conjugated donkey anti-mouse IgG (1:400; Life Technologies) for 2 hours. Sections were dehydrated and 16 dipped in Kodak NTB autoradiography emulsion. The autoradiograms were developed after 9 days. The 17 fluorescent signal of Alexa Fluor 488 was pseudo-colored to red for better visibility of dual-labeled cells. 18
19

Fluorescent OATP1c1 in situ hybridization combined with GFAP immunofluorescence 20
Hybridizations were performed on both fresh-frozen control rat sections, and sections from four normal 21 paraformaldehyde-perfused rats. Paraformaldehyde-perfusion was performed as previously described 22 (36). Briefly, rats were anesthetized with an overdose of pentobarbital (50 mg/kg) and perfused 23 transcardially with PBS followed by 4% paraformaldehyde. The brains were postfixed by immersion in 24 4% paraformaldehyde, cryoprotected in 20% sucrose in PBS overnight, then snap-frozen on dry ice. 25
Serial 20 μm coronal sections were cut on a cryostat, collected in cryoprotectant solution and stored at -26 20°C until used. Fluorescent in situ hybridization for fresh-frozen and paraforaldehyde-perfused sections 1 was performed as previously described (15, 36) . The digoxigenin-labeled probe was detected with 2 peroxidase-conjugated Fab fragments of sheep anti-digoxigenin antibody (1:100, Roche). The 3 hybridization signal was amplified with biotinylated tyramide for 30 min using the TSA amplification kit 4 (Perkin Elmer), and visualized by Alexa 488-conjugated Streptavidin (1:500; Life Technologies). 5
Sections were reacted with murine GFAP antibody as above, and detected with Cy3-conjugated donkey 6 anti-mouse IgG (Jackson ImmunoResearch). Sections were then coverslipped with Vectashield 7 containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories). 8 9
Immunofluorescence for OATP1c1 and MCT8 10
For MCT8 immunofluorescence, mounted fresh-frozen sections were fixed with 4% paraformaldehyde in 11 0.1M phosphate buffer (pH 7.4) for 15 min. For OATP1c1 immunofluorescence, sections were fixed 12 with methanol at −20°C for 5 min. Sections were permeabilized with 0.25% Triton-X-100 for 30 min, 13 blocked with 2% normal horse serum in PBS, and incubated overnight in a rabbit antiserum against 14 human MCT8 (raised against amino acids 527-539; #1306, gift from Dr. Theo J. Visser) or a rabbit 15 antiserum against human OATP1c1 (raised against amino acids 697-712; #3516, gift from Dr. Theo J. 16 Visser), both diluted at 1:1,000. The primary antisera were detected with Alexa Fluor 488-conjugated 17 donkey anti-rabbit IgG diluted at 1:400 (Jackson Immunoresearch). Immunostaining with both antisera 18 resulted in the same patterns reported earlier (26, 37) . 19
20
Image analysis 21
In situ hybridization signals were compared between sections from a single hybridization experiment 22
where all conditions and exposure times were identical. Darkfield images of OATP1c1 in situ 23 hybridization were analyzed with ImageJ software (public domain at http://rsb.info.nih.gov/ij). To 24 maximize the analysis of OATP1c1 signal in blood vessels, hybridizations were analyzed in the 25 hypothalamus where no significant signal was detected in astrocytes after 9 days exposure in mice or 5 26 days exposure in rats. Images were taken with a 5× objective at the level of the paraventricular nucleus 1 (mice) or the dorsomedial nucleus (rats), and integrated density values were calculated. From the two rat 2 OATP1c1 hybridizations, only the 5 day exposure experiment was used for quantitative image analysis. 3
Images from both the 9 and 5 days exposure experiments were used to illustrate the magnitude of changes 4 in OATP1c1 hybridization signal. To quantify vascular MCT8 hybridization in mice, blood vessel 5 segments with clear hybridization signal were counted in the thalamus and hypothalamus in 3 sections per 6 mouse at the rostro-caudal level of the median eminence. In these regions, the low neuronal hybridization 7 signal allowed easier identification of labeled blood vessels than in cortical regions. OATP1c1 8 immunofluorescence in blood vessels was quantified in rats using ImageJ. Images were taken with a 20× 9
objective of an area with high density of blood vessels in the midline thalamus. The area covered by 10 immunofluorescently labeled vessels (pixel number) was measured by subtracting non-labeled areas (i.e., 11 dark pixels) from the image using the threshold tool and the same threshold value for all images. 12 Hematoxylin and eosin staining was used to facilitate the identification of arachnoid veins in rats. 13
14
Statistical analysis 15
Data are presented as mean ± SEM. Quantitative PCR data were expressed as RQ (mean +/-SEM). 16
Quantitative PCR data from cortex and image analysis data were compared between groups by one-way 17 ANOVA and Newman-Keuls multiple comparison post-hoc test. Quantitative PCR data from the 18 leptomeninges were compared by Student's t test. 19 20
Results
21
Effect of LPS on OATP1c1 expression in the brain 22
OATP1c1 mRNA. LPS administration similarly affected OATP1c1 expression in mice and rats. 23
OATP1c1 mRNA levels decreased profoundly within 9h after LPS injection, as demonstrated by a 24 striking reduction in hybridization signal across the forebrain (Fig. 1A, 1B) . Emulsion autoradiography 25 revealed that this reduction was due to a loss of hybridization signal specifically in blood vessels, but not 26 astrocytes. Vascular OATP1c1 expression decreased uniformly in the forebrain, but the course of this 1 response could be followed most clearly in the hypothalamus ( Fig. 2A) where hybridization signal in 2 astrocytes was the lowest among forebrain regions. Hybridization signal in vessels decreased 3 significantly as soon as 2h after LPS, and markedly by 4h ( Fig. 2A) . Vascular hybridization signal was 4 virtually absent in mice 9h after LPS injection, except light labeling of the highly vascularized 5 hypothalamic paraventricular nucleus ( Fig. 2A) . A similar reduction was observed in rats, where only 6 scattered blood vessels with light hybridization signal were detected at 9h after LPS (in the hybridization 7 experiment with the longer, 9 day autoradiography exposure). Moderate labeling remained only in some 8 vessels of the paraventricular and supraoptic nuclei ( Fig. 3A ; also in Fig 1A) ; in fact, vessels in these two 9 nuclei were more intensely labeled than elsewhere, even in control rats. The loss of OATP1c1 10 hybridization signal in blood vessels is also demonstrated in images from the cerebral cortex in Figs. 2B 11 and 3A. 12
Hybridization signal in astrocytes did not change noticeably in either species, and remained comparable 13 to control levels 9h after LPS, as demonstrated in images from the mouse and rat cortex (Fig. 2B, 3A) . 14 Notably, OATP1c1 mRNA in astrocytes varied greatly between brain regions, confirming recent studies 15 (23, 27) . In mice, OATP1c1 mRNA was easily detected in hippocampal and cortical astrocytes, while it 16 was not detected in hypothalamic astrocytes with the exposure time used in this experiment. In rats, 17 differences in astrocytic OATP1c1 expression were confirmed by both fluorescent (Fig. 3B) and 18 radioactive in situ hybridization. Hybridization signal was moderate to intense in astrocytes of the cortex, 19 hippocampus, striatum, and ventrolateral thalamus, whereas it was much lighter in astrocytes of the 20 hypothalamus, such as in the ventromedial nucleus (Fig. 3B) . 21
In both species, vascular OATP1c1 hybridization signal increased above control levels during the 22 recovery phase from endotoxemia. In mice, OATP1c1 mRNA was still below control levels at 24h, but 23 increased markedly at 48h after LPS (Fig. 2A) . In rats, upregulation of OATP1c1 mRNA in blood 24 vessels could be observed at both 24h and 48h after LPS (Fig. 3A) . Conspicuously increased signal in 25 vessels was observed in one out of four rats in the 24h LPS group, and three out of four rats in the 48h 26 LPS group. Markedly increased OATP1c1 mRNA at 24h after LPS was confirmed in another experiment 1 (2 out of 2 rats; data not shown). This indicates that the timing of post-endotoxemic increase in vascular 2 OATP1c1 mRNA can vary among individual rats. Image analysis results from mice and rats representing 3 vascular OATP1c1 mRNA expression at each time point following LPS injection are presented in Fig.  4 4A. Quantitative RT-PCR data from cortical samples confirmed the in situ hybridization results, as 5
OATP1c1 mRNA was significantly decreased 9h after LPS injection in both species (Fig. 4B) . At 48h 6 after LPS, OATP1c1 mRNA levels were not different from control levels by quantitative PCR (Fig. 4B) . 7
In the choroid plexus, OATP1c1 hybridization signal was consistently reduced 9h after LPS in mice (Fig.  8   1B) , but not rats. In tanycytes, OATP1c1 mRNA expression was extremely intense in rats (Supplemental 9 Fig. 1 ), but conspicuously absent in mice (Supplemental Fig. 2 ). LPS did not affect OATP1c1 expression 10 in rat tanycytes. 11
OATP1c1 protein. Immunofluorescence for OATP1c1 gave clear labeling of blood vessels in the rat brain 12 with low background, whereas in mice the labeling was less sensitive and less clear due to higher 13 background levels. The antiserum did not label astrocytes. Immunostaining of blood vessels did not 14 differ between control, 2h and 4h LPS groups, but visibly decreased at 9h and 24h (5A, 5B). At 24h, 15 when the decrease was significant by image analysis (Fig. 4A) , only scattered major vessel segments were 16 labeled in both species (Fig. 5A , 5B). OATP1c1 immunostaining in vessels at 48h after LPS was similar 17 to controls (Fig. 5A , 5B). OATP1c1 immunostaining was intense in rat tanycytes (Supplemental Fig. 1) , 18 whereas in mice it was observed selectively in lateral beta (beta-1) tanycytes in the floor of the third 19 ventricle (Supplemental Fig. 2) . The presence of OATP1c1 immunoreactivity in mouse tanycytes is in 20 agreement with a previous report by Roberts et al. (26) that used highly specific antibodies. 21
22
Effect of LPS on MCT8 expression in the brain 23
MCT8 mRNA. LPS similarly affected MCT8 expression in mice and rats. The hybridization patterns in 24 control brains were identical to what was previously described (25). Several neuronal populations were 25 labeled with variable, light to intense signal, and scattered larger blood vessels were labeled with 26 moderate or light signal (Fig. 1C) . Rat tanycytes were intensely labeled, and extremely intense signal 1 labeled mouse tanycytes and the choroid plexus in both species (Fig. 1C) . Neuronal MCT8 expression 2 did not noticeably change at any time after LPS injection in both species (Fig. 1C) . In contrast, MCT8 3 mRNA expression in blood vessels changed markedly in response to LPS. In mice, the intensity of 4 vascular labeling decreased gradually from 2h until 9h, when hybridization signal was no longer detected 5 in vessels (Fig. 6A) . A similar trend was observed in rats, with noticeably less numerous and less 6 intensely labeled blood vessels at 4h, and only occasional, lightly labeled vessels visible at 9h (Fig. 6B) . 7
In mice, both the number of detected vessel segments and their signal intensity increased at 24h after LPS 8 compared to control mice, and even more strikingly at 48h (Fig. 1C, 6A ). The quantification of labeled 9 vessels in mice is presented in Fig. 4A . In rats, labeling of blood vessels was comparable to control levels 10 at 24h, but increased markedly by 48h after LPS (Fig. 6B) . Quantitative PCR from the mouse cortex did 11 not detect significant changes in MCT8 mRNA after LPS (Fig. 4B ). In the rat cortex, MCT8 mRNA 12 tended to decrease at 9h albeit not significantly, but significantly increased 48h after LPS (Fig. 4B) . 13 MCT8 protein. MCT8 immunolabeling in blood vessels was not different from control levels at 2, 4, 9 or 14 48h after LPS in both species. Only a slight decrease in labeling was observed at 24h in mice (Fig. 5C) . 15
Intense MCT8 immunofluorescence was observed in axons in both species, in accordance with our 16 previous description of specific axonal MCT8 labeling (37). MCT8-containing axons were present in 17 most brain regions, but unaffected by LPS. 18
19
Effect of LPS on OATP1c1, MCT8 and D2 mRNAs in the rat leptomeninges 20
Since we previously observed that LPS administration induces robust D2 expression in the leptomeninges 21 of rats (15), we also studied the expression of TH transporters in this tissue. OATP1c1 mRNA-22 expressing cells were observed in arachnoid veins, but not arteries or in the arachnoid tissue itself (Fig.  23   7A) . Following LPS, OATP1c1 hybridization signal could no longer be detected in the wall of the veins 24 at 2, 4 or 9h later (Fig. 7A) , but returned to control levels by 24h, and remained normal at 48h. 25
Conversely, D2 mRNA was induced in the wall of the arachnoid veins but not arteries following LPS (Fig  26 7A ), which we did not previously recognize (15). Moderate to intense MCT8 hybridization signal was 1 observed in the leptomeningeal layers between the hippocampus and thalamus (Fig. 7A) , and the dorsal 2 third ventricle adjacent to the choroid plexus. This signal did not change significantly following LPS 3 administration. MCT8 hybridization signal in the arachnoid covering the outer brain surface was 4 uncertain, as control hybridizations with the sense transcript also yielded labeling in this location, 5 although less intensely than the antisense probe. By quantitative PCR from leptomeninges removed from 6 the basal forebrain, OATP1c1 mRNA was reduced to approximately 10% of control level 9h after LPS 7 injection, MCT8 mRNA did not change, while D2 mRNA increased 86-fold on average (Fig. 7B) . 8 9
Discussion 10
While data have been accumulating on cell-type specific regulation of TH action in the brain, regulation 11 of TH transport is poorly understood. In the present study, regulation of TH transporters was studied in 12 the forebrain using a model of non-thyroidal illness syndrome, a condition known to evoke marked 13 changes in tissue TH availability (1, 2). In particular, we report changes in OATP1c1 and MCT8 14 expression in the rodent brain in response to LPS administration, with the following main findings: 1) 15
OATP1c and MCT8 mRNAs decrease rapidly and robustly in blood vessels; 2) this effect is cell-type 16 specific as OATP1c1 and MCT8 mRNA levels remain unaltered in astrocytes and neurons; 3) a robust 17 decrease in OATP1c1 but not MCT8 protein levels in vessels follows hours later; 4) during recovery from 18 endotoxemia, OATP1c1 and MCT8 mRNA levels increase markedly in blood vessels above control 19 levels; 5) these changes occur in both mice and rats. In addition, we describe OATP1c1 expression in 20 arachnoid veins but not arteries that respond to LPS in a similar way as parenchymal blood vessels, and 21 MCT8 mRNA in part of the rat leptomeninges. 22 MCT8 and OATP1c1 have complementary functions in the blood-brain barrier, and work in tandem to 23 allow TH access to the brain (24). The parallel changes in OATP1c1 and MCT8 mRNAs in brain vessels 24 during endotoxemia further corroborates the functional link between these transporters, and suggest a 25 common mechanism regulating the expression of these genes during inflammation. The mechanisms by 26 which rapid downregulation of both transporter mRNAs occurs is unknown, but could be a direct effect of 1 cytokines or other associated inflammatory signals that are associated with endotoxin administration. 2 However, this response was specific to cells comprising the brain vasculature, such as endothelial cells 3 known to express these transporters (26, 34, 38) and possibly also pericytes, while OATP1c1 and MCT8 4 mRNA levels remained unchanged in astrocytes and neurons. One possibility to explain the latter 5 phenomenon is that the extracellular signal that down-regulates MCT8 and OATP1c1 expression in 6 vessels has limited access to astrocytes and neurons inside the blood-brain barrier. Alternatively, the 7 signal may be present in the brain parenchyma, but due to intrinsic properties of astrocytes and neurons, 8 has no effect on OATP1c1 or MCT8 mRNA. The latter might be explained by the lack of receptors for 9 the signal molecule, or that the signaling pathway activated is not coupled to the mechanism that changes 10 the transcription of the transporter genes. 11
The marked increase in OATP1c1 and MCT8 mRNAs during the recovery period from endotoxemia may 12 be secondary to low intracellular TH levels in microvascular cells, supported by data that OATP1c1 in rat 13 brain microvessels is upregulated by hypothyroidism (28). However, regulation of OATP1c1 and MCT8 14 mRNAs by TH was not observed in congenitally hypothyroid mice (25), raising the possibility that 15 increased OATP1c1 and MCT8 mRNA expression may be a rebound effect independent of TH 16
concentration. 17
At the protein level, OATP1c1 decreased in brain vessels in a similarly robust manner as OATP1c1 18 mRNA, but only several hours later. This delay likely reflects the turnover rate of OATP1c1 protein in 19 cells of the blood-brain barrier. In contrast, only a modest decrease in vascular MCT8 immunostaining 20 was observed in mice. A possible explanation is that the half-life of MCT8 may be substantially longer 21 than that of OATP1c1, and in our model, the inflammatory state may have been too transitory to see a 22 significant decrease in the MCT8 protein. Thus, an inflammation model of longer duration may be 23 necessary to more definitively address whether MCT8 decreases similar to OATP1c1. Since our analysis 24 did not provide information on the subcellular location of the transporters, it is also conceivable that 25 internalization of OATP1c1 and/or MCT8 from the cell membrane could result in a more rapid decrease 1 in TH transport before a decrease in protein levels is realized. 2
Access of TH to most of the brain parenchyma primarily occurs via the blood-brain barrier, and much less 3 via the blood-cerebrospinal fluid barrier (39). Since deficiency in either OATP1c1 or MCT8 is sufficient 4 to reduce brain TH uptake (24, 32), downregulation of these transporters in brain vessels during 5 inflammation suggests diminished TH uptake into the brain parenchyma and may contribute to common 6 symptoms associated with illness such as fatigue, depressed mood, and impaired neurocognitive function. 7
In support, a recent clinical study reported that certain OATP1c1 polymorphisms are associated with 8 fatigue and depression in a population of patients with adequately treated hypothyroidism (40). 9
Inflammatory regulation of OATP1c1 and MCT8 was strikingly different from that observed for D2 that 10 is highly inducible by the inflammatory transcription factor, nuclear factor-kappa B (NF-κB) (11, 41) . 11 LPS induces D2 via NF-κB in tanycytes (7, 15), and probably in meningeal fibroblasts (15). In contrast, 12
OATP1c1 and MCT8 expression did not increase following LPS in any cell type in the brain, and 13 markedly decreased in cells of brain blood vessels. The opposite regulation of D2 and OATP1c1/MCT8 14 by inflammation raises the possibility that during inflammation, TH availability may not be uniform 15 throughout the brain. The downregulation of OATP1c1 and MCT8 at the blood-brain barrier suggests 16 decreased TH availability within the brain parenchyma, whereas induction of D2 suggests increased TH 17 availability in the leptomeninges and choroid plexus (15). Therefore, inflammation may result in both 18 "hypothyroid" and "hyperthyroid" compartments in the rat brain. As we previously hypothesized (15), 19 increased TH levels in the leptomeninges and choroid plexus, where the proinflammatory reaction is the 20 most intense following LPS administration (42-47), may serve to control inflammatory processes and 21 improve macrophage function (6, 8, (16) (17) (18) . It can be also speculated, however, that at the same time 22 decreased TH levels might be adaptive for cells in the brain parenchyma. While further research will be 23 necessary to understand the pathophysiological role of these changes, the present findings underscore that 24 TH availability may differ significantly for different cell types of a single organ during the non-thyroidal 25 illness syndrome. 26
In conclusion, OATP1c1 and MCT8 expression is downregulated in the blood-brain barrier during 1 inflammation, suggesting decreased TH uptake into the rodent brain. TH uptake studies in inflammation 2 models will be essential in the future to test the importance of TH transporter downregulation on TH 3 delivery to the brain. 
